Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible securities fraud by Curanex Pharmaceuticals and its executives following extreme stock price volatility after its IPO in August 2025. The stock price surged to $9.16 before plummeting to $1.51 amid heavy trading volume, leading to a trading halt. Shareholders who suffered losses may have claims, and the law firm invites them to contact for potential legal action. This probe could impact investor confidence and the company's future market activity.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
In 2026, Alphabet has delivered outstanding returns over one, three, and five years, contrasting with struggles faced by other hyperscalers. The semiconductor sector remains highly cyclical, impacting both business performance and stock prices. A com...
IES Holdings has been upgraded to a Buy rating due to a record backlog increase of 63% to $3.9 billion and ongoing capacity expansion. The company’s Communications and Infrastructure Solutions segments, which have higher margins and growth potential,...
Taiwan Semiconductor Manufacturing Company (TSMC) reported a 23.4% increase in second-quarter profit from the previous quarter, surpassing analyst estimates. The company's net income reached NT$706.56 billion ($39.45 billion), a record high for the f...
National Beverage faces stagnant growth as LaCroix volumes have declined for four straight years, reducing brand excitement. The stock trades at reasonable multiples reflecting muted growth and no clear catalysts for upside. Despite stable gross marg...
